Cargando…
906. Risk of Shingles among Patients Aged 45–49 versus 50–54 Years in the US, by Immune Status
BACKGROUND: Shingles burden has historically focused on older adults, with the currently licensed vaccine in the US approved for adults aged ≥50 years. Our study aimed to estimate the incidence of shingles among adults aged 45–49 years and to ascertain whether the adjusted incidence rate (IR) was si...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678037/ http://dx.doi.org/10.1093/ofid/ofad500.951 |